SCHEMBL858138

SCHEMBL858138

FC(F)(F)Sc1ccc(-c2ccnc3[nH]ccc23)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 6/20 0.59
CHUK O15111 5/20 0.59
AURKB Q96GD4 2/20 0.59
DAPK3 O43293 1/20 0.59
JAK2 O60674 1/20 0.59
PRKD3 O94806 1/20 0.59
MAP4K4 O95819 1/20 0.59
PAK4 O96013 1/20 0.59
CSF1R P07333 1/20 0.59
RET P07949 1/20 0.59
IGF1R P08069 1/20 0.59
FGFR1 P11362 1/20 0.59
PRKACA P17612 1/20 0.59
FLT1 P17948 1/20 0.59
LTK P29376 1/20 0.59
GRK5 P34947 1/20 0.59
KDR P35968 1/20 0.59
MAP2K2 P36507 1/20 0.59
MAPK8 P45983 1/20 0.59
CSNK1A1 P48729 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL858003 0.81 IKBKB (0.64) IKBKBCHUKAURKBDAPK3JAK2
SCHEMBL30173273 0.80 PRKCI (0.46) IKBKBCHUKAURKBDAPK3JAK2
SCHEMBL12127926 0.79 IKBKB (0.70) IKBKBCHUKAURKBDAPK3JAK2
SCHEMBL7982849 0.77 ABL1 (0.61) IKBKBCHUKAURKBDAPK3JAK2
SCHEMBL12127858 0.75 IKBKB (0.93) IKBKBCHUKAURKBDAPK3JAK2
SCHEMBL4771643 0.75 IKBKB (0.70) IKBKBCHUKAURKBDAPK3JAK2
SCHEMBL31065020 0.75 IKBKB (0.70) IKBKBCHUKAURKBDAPK3JAK2
SCHEMBL4792517 0.75 IKBKB (0.70) IKBKBCHUKAURKBDAPK3JAK2
SCHEMBL30674332 0.75 IKBKB (0.70) IKBKBCHUKAURKBDAPK3JAK2
SCHEMBL26930376 0.75 IKBKB (0.70) IKBKBCHUKAURKBDAPK3JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143271-B2 Compounds and methods for kinase modulation, and indications therefor PLEXXIKON INC. (US) 2012-03-27 US disclosed
US-8143271-B2 Compounds and methods for kinase modulation, and indications therefor PLEXXIKON INC. (US) 2012-03-27 US disclosed